Afuco™ Anti-ERBB2 ADCC Therapeutic Antibody (Pertuzumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to ERBB2. Pertuzumab (also called 2C4, trade name pertuzumab) is a monoclonal antibody. The first of its class in a line of agents called "HER dimerization inhibitors". By binding to HER2, it inhibits the dimerization of HER2 with other HER receptors, which is hypothesized to result in slowed tumor growth.
Supplier Creative Biolabs
Product # AFC-TAB-053
Pricing Inquiry
Host Human
Target ERBB2
Species Reactivity Human
Type ADCC enhanced antibody
Applications FuncS, IF, Neut, ELISA, FC, IP
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback